![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
CD226: a potent driver of antitumor immunity that needs to be maintained
-
Article
NK cell dysfunction in patients with COVID-19
-
Article
The use of supercytokines, immunocytokines, engager cytokines, and other synthetic cytokines in immunotherapy
Cytokines exert powerful immunomodulatory effects that are critical to physiology and pathology in humans. The application of natural cytokines in clinical studies has not been clearly established, and there a...
-
Article
Increased expression of adenosine A3 receptor in tumor-infiltrating natural killer cells
-
Article
IL-33-induced reactive oxygen species are required for optimal metabolic programming in group 2 innate lymphoid cells
-
Article
Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
Checkpoint blockade enhances effector T cell function and has elicited long-term remission in a subset of patients with a broad spectrum of cancers. TIGIT is a checkpoint receptor thought to be involved in med...